Related references
Note: Only part of the references are listed.Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation Study
Diederik J. Hoppener et al.
JNCI CANCER SPECTRUM (2021)
y Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation Study
Diederik J. Hoppener et al.
JNCI CANCER SPECTRUM (2021)
Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis
Diederik J. Hoppener et al.
BRITISH JOURNAL OF CANCER (2020)
Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases
Florian E. Buisman et al.
CLINICAL & EXPERIMENTAL METASTASIS (2020)
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer
T. Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Salvage treatment for recurrences after first resection of colorectal liver metastases: the impact of histopathological growth patterns
Pieter M. H. Nierop et al.
CLINICAL & EXPERIMENTAL METASTASIS (2019)
Prediction of Histopathologic Growth Patterns of Colorectal Liver Metastases with a Noninvasive Imaging Method
Jin Cheng et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases
Boris Galjart et al.
ANGIOGENESIS (2019)
Consensus guidelines for the use and interpretation of angiogenesis assays
Patrycja Nowak-Sliwinska et al.
ANGIOGENESIS (2018)
The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients
Marc Van den Eynde et al.
CANCER CELL (2018)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
International consensus guidelines for scoring the histopathological growth patterns of liver metastasis
Pieter-Jan van Dam et al.
BRITISH JOURNAL OF CANCER (2017)
Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor Margin
Pulathis N. Siriwardana et al.
MEDICINE (2016)
Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases
Sophia Frentzas et al.
NATURE MEDICINE (2016)
Growth pattern of colorectal liver metastasis as a marker of recurrence risk
R. L. Eefsen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983
Erik Tanis et al.
EUROPEAN JOURNAL OF CANCER (2015)
Prognosis according to histochemical analysis of liver metastases removed at liver resection
S. M. Brunner et al.
BRITISH JOURNAL OF SURGERY (2014)
The morphological growth patterns of colorectal liver metastases are prognostic for overall survival
Kare Nielsen et al.
MODERN PATHOLOGY (2014)
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger et al.
LANCET ONCOLOGY (2013)
The histological growth pattern of colorectal cancer liver metastases has prognostic value
Gert G. Van den Eynden et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Microsatellite Instability in Colorectal Cancer
C. Richard Boland et al.
GASTROENTEROLOGY (2010)
The anticancer immune response: indispensable for therapeutic success?
Laurence Zitvogel et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases
Dan G. Blazer et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
Bernard Nordlinger et al.
LANCET (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement Guidelines for Reporting Observational Studies
Erik von Elm et al.
EPIDEMIOLOGY (2007)
Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery
L. Rubbia-Brandt et al.
ANNALS OF ONCOLOGY (2007)
Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia
F Stessels et al.
BRITISH JOURNAL OF CANCER (2004)
Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia
PB Vermeulen et al.
JOURNAL OF PATHOLOGY (2001)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
